China Isotope & Radiation Corporation

China Isotope & Radiation Corporationverified

1763.HK

Price:

$20.8

Market Cap:

$6.02B

China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Independent Clinical Medical and Laboratory Services, and Other Business. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals; UBT kits and analyzers; and in vitro immunoassay diagnostic reagents and kits. The Radioactive S...[Read more]

Industry

Medical - Devices

IPO Date

2018-07-06

Stock Exchange

HKSE

Ticker

1763.HK

The PE Ratio as of December 2025 (TTM) for China Isotope & Radiation Corporation (1763.HK) is 14.15

According to China Isotope & Radiation Corporation’s latest financial reports and current stock price. The company's current PE Ratio is 14.15. This represents a change of 212.61% compared to the average of 4.53 of the last 4 quarters.

China Isotope & Radiation Corporation (1763.HK) Historical PE Ratio (quarterly & annually)

How has 1763.HK PE Ratio performed in the past?

The mean historical PE Ratio of China Isotope & Radiation Corporation over the last ten years is 16.57. The current 14.15 PE Ratio has changed 8.44% with respect to the historical average. Over the past ten years (40 quarters), 1763.HK's PE Ratio was at its highest in in the June 2020 quarter at 22.49. The PE Ratio was at its lowest in in the December 2024 quarter at 3.23.

Quarterly (TTM)
Annual

Average

16.57

Median

15.68

Minimum

8.02

Maximum

33.39

China Isotope & Radiation Corporation (1763.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of China Isotope & Radiation Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 82.65%

Maximum Annual PE Ratio = 33.39

Minimum Annual Increase = -48.88%

Minimum Annual PE Ratio = 8.02

Quarterly (TTM)
Annual
YearPE RatioChange
20248.02-21.01%
202310.165.43%
20229.63-43.56%
202117.07-48.88%
202033.3982.65%
201918.2855.49%
201811.76-17.78%
201714.30-34.87%
201621.953.72%

China Isotope & Radiation Corporation (1763.HK) Average PE Ratio

How has 1763.HK PE Ratio performed in the past?

The current PE Ratio of China Isotope & Radiation Corporation (1763.HK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

9.27

5-year avg

15.65

10-year avg

16.57

China Isotope & Radiation Corporation (1763.HK) PE Ratio vs. Peers

How is 1763.HK’s PE Ratio compared to its peers?

China Isotope & Radiation Corporation’s PE Ratio is less than AK Medical Holdings Limited (19.64), less than MicroPort NeuroTech Limited (27.75), less than Gushengtang Holdings Limited (18.52), greater than Beijing Tong Ren Tang Chinese Medicine Company Limited (13.84), greater than China Shineway Pharmaceutical Group Limited (7.12), greater than Jinxin Fertility Group Limited (-6.39), less than Zylox-Tonbridge Medical Technology Co., Ltd. (44.52), greater than Tong Ren Tang Technologies Co. Ltd. (11.88), less than Beauty Farm Medical and Health Industry Inc. (20.70), greater than Yidu Tech Inc. (-55.47),

Build a custom stock screener for China Isotope & Radiation Corporation (1763.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like China Isotope & Radiation Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

China Isotope & Radiation Corporation (1763.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like China Isotope & Radiation Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is China Isotope & Radiation Corporation's PE Ratio?

How is the PE Ratio calculated for China Isotope & Radiation Corporation (1763.HK)?

What is the highest PE Ratio for China Isotope & Radiation Corporation (1763.HK)?

What is the 3-year average PE Ratio for China Isotope & Radiation Corporation (1763.HK)?

What is the 5-year average PE Ratio for China Isotope & Radiation Corporation (1763.HK)?

How does the current PE Ratio for China Isotope & Radiation Corporation (1763.HK) compare to its historical average?